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Abstract
Quantile-dependent penetrance is proposed to occur when the phenotypic expression of a SNP depends upon the
population percentile of the phenotype. To illustrate the phenomenon, quantiles of height, body mass index (BMI), and
plasma lipids and lipoproteins were compared to genetic risk scores (GRS) derived from single nucleotide polymorphisms
(SNP)s having established genome-wide significance: 180 SNPs for height, 32 for BMI, 37 for low-density lipoprotein (LDL)-
cholesterol, 47 for high-density lipoprotein (HDL)-cholesterol, 52 for total cholesterol, and 31 for triglycerides in 1930
subjects. Both phenotypes and GRSs were adjusted for sex, age, study, and smoking status. Quantile regression showed that
the slope of the genotype-phenotype relationships increased with the percentile of BMI (P=0.002), LDL-cholesterol
(P=3610
28), HDL-cholesterol (P=5610
26), total cholesterol (P=2.5610
26), and triglyceride distribution (P=7.5610
26), but
not height (P=0.09). Compared to a GRS’s phenotypic effect at the 10
th population percentile, its effect at the 90
th
percentile was 4.2-fold greater for BMI, 4.9-fold greater for LDL-cholesterol, 1.9-fold greater for HDL-cholesterol, 3.1-fold
greater for total cholesterol, and 3.3-fold greater for triglycerides. Moreover, the effect of the rs1558902 (FTO) risk allele was
6.7-fold greater at the 90
th than the 10
th percentile of the BMI distribution, and that of the rs3764261 (CETP) risk allele was
2.4-fold greater at the 90
th than the 10
th percentile of the HDL-cholesterol distribution. Conceptually, it maybe useful to
distinguish environmental effects on the phenotype that in turn alters a gene’s phenotypic expression (quantile-dependent
penetrance) from environmental effects affecting the gene’s phenotypic expression directly (gene-environment interaction).
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Introduction
Genome-wide association studies have shown that for most
traits, a few, common, single nucleotide polymorphisms (SNP)
account for a small proportion of the genetic variance [1]. Meta-
analyses have been instrumental in culling a select subset of true
associations from the large number of false positive results [2].
With respect to the analyses of the data per se, statistical concerns
have focused on adjustment for covariates, transformations for
nonnormal phenotypes, and selection of additive vs. dominant
phenotypic expression of the allelic dose [3]. Major questions
remain as to why SNPs explain only small proportions of the
phenotypic variance for traits showing high genetic inheritance
from twin and family studies [4].
The classical regression model assumes that the relationship
between the independent variable (e.g., genotype) and dependent
variable (e.g., phenotype) applies to all quantiles of the dependent
variable [5]. For example, the 0.39 kg/m
2 per allele increase in
body mass index (BMI) for the rs1558902 (FTO gene) [6] is
assumed to apply equally to healthy weight, overweight, and obese
individuals. There is, however, no a priori biological rationale for
this premise.
We hypothesize that describing the effect of single nucleotide
polymorphisms (SNP) by their standard regression slope may
fundamentally mischaracterize their relationship, and contribute
in a modest way to underestimating the proportion of the variance
explained by genetic variants. Specifically, some of the missing
genetic variance could be due to the misperception that the same
genotype-phenotype relationship applies whether the phenotypic
value is high, intermediate, or low relative to its population
distribution. Although there are often statistical advantages to
comparing the genotypic frequencies at the phenotypic extremes
[7], differing penetrance for the tails of the distribution would also
argue against comparing their genotypic frequencies to identify
their genetic determinants.
To test this hypothesis, this paper examines the relationships of
linear combinations of SNPs shown to predict lipoprotein
concentrations, BMI, and height in published meta-analyses
[6,8,9]. Genetic risk scores (GRS) for BMI, plasma lipid and
lipoprotein concentrations, and height were created from the
published meta-analyses of individuals of European ancestry
(Table 1 in Speliotes et al., 2010 [6]; supplementary Table 2 in
Teslovich et al., 2010 [8], supplementary Table 1 in Lango et al.,
2010 [9]). The meta-analyses identified genome-wide statistical
significance for 32 SNPs with BMI, 37 SNPs with low-density
lipoprotein (LDL)-cholesterol concentrations, 47 SNPs with high-
density lipoprotein (HDL)-cholesterol concentrations, 52 SNPs
with total cholesterol concentrations, 31 SNPs with plasma
triglyceride concentrations, and 180 loci for height. Each
individual was given a GRS that was the summation of the
PLoS ONE | www.plosone.org 1 January 2012 | Volume 7 | Issue 1 | e28764product of the number of minor alleles for each SNP and their
published per allele phenotypic effect (e.g., #minor alleles
SNP1*its published per allele effect on the phenotype + #minor
alleles SNP2*its published per allele effect on the phenotype,….).
Height, BMI, lipids, and GRSs were adjusted for sex, age (age and
age
2), study, and smoking status. In each case, the unit of measure
of the GRS was the predicted kg/m
2 (BMI), mg/dL (lipids and
lipoproteins), or z-score increase (height). In addition, two SNPs
are examined that have shown consistent replication across
multiple studies: BMI vs. rs1558902 (FTO) [6], and HDL-
cholesterol vs. rs3764261 (CETP) [8]. The results suggest that
phenotypic expressions of SNPs are significantly related to the
percentile of the lipoprotein and BMI distribution, and that
measuring a SNP’s effect by the standard regression slope may
underestimate its true genetic impact. The consistency of the
results across multiple SNPs and traits suggest this phenomenon
may not be uncommon.
Results
LDL-cholesterol
Standard regression analyses showed that when adjusted
for covariates, plasma LDL-cholesterol concentrations increased
(slope6SE) 0.80160.085 mg/dL per unit increase in the
GRSLDL-cholesterol (Table 1, 4.4% of the variance, P,10
215).
Figure 1 (upper panel) presents the regression analyses for selected
quantiles of the LDL-cholesterol distribution. It shows that the slopes
became progressively larger at the higher quantiles of the LDL-
distribution. These slopes, along with the slopes for the other
quantiles, are presented in the lower panel’s graph of the regression
slopes (Y-axis) as a function of the quantile of the LDL-cholesterol
distribution (X-axis). The Y-axis of the lower panel represents the
slopes rather than the LDL-cholesterol concentrations themselves
(comparewiththeupperpanel).Specifically,theY-axisrepresentsthe
LDL-cholesterol vs. GRSLDL-cholesterol slope at the 5
th quantile of the
LDL-cholesterol distribution, the 6
th quantile of the LDL-cholesterol
distribution,…, and the 95
th quantiles of the LDL-cholesterol
distribution. Dashed lines present the standard errors for the slopes
at eachquantilevalue.Thefigureshowsthateachunitincreaseinthe
GRSLDL-cholesterol was associated with an LDL-cholesterol increase of
0.28160.099 mg/dL at the 10
th percentile of the LDL-distribution,
0.65260.111 mg/dL at the 25
th percentile, 0.77160.098 mg/dL at
the 50
th percentile (the median), 0.90960.110 mg/dL at the 75
th
percentile, and 1.38460.195 mg/dL at the 90
th percentile of the
LDL-cholesteroldistribution.IftheslopesrelatingLDL-cholesterolto
the GRSLDL-cholesterol were the same throughout the LDL-cholesterol
distribution, as traditionally assumed, then the upper graph would
present parallel regression lines, and the lower graph would present a
simple horizontal line. In fact, the graph shows that the increase in
LDL-cholesterol became progressively more positive with increasing
percentile of the its distribution, such that on average each 1-percent
increase wasassociated witha 0.010660.0019 mg/dL increase in the
slope (P=3610
28). The LDL-cholesterol-GRS slope was 4.93-fold
greater at the 90
th than at the 10
th LDL-cholesterol percentile.
The absolute difference in slopes at the 10
th and 90
th quantiles
(1.10 mg/dL) exceeded the traditional regression slope
(0.801 mg/dL) by 38%. The 95% confidence interval for the
standard regression slope (i.e., 61.96*SE) included only those
slopes between the 24
th and 77
th quantiles of Figure 1,
misrepresenting the LDL-cholesterol-GRS slope for 46% of the
LDL-cholesterol distribution. Allowing the slopes to increase with
the quantiles of the LDL-distribution improved the proportion of
the variance explained by the GRSLDL-cholesterol by 20.1% (from
4.43% to 5.61% of the variance).
HDL-cholesterol
Standard regression analyses showed that when adjusted
for covariates, plasma HDL-cholesterol concentrations in-
creased (slope6SE) 0.86060.074 mg/dL per increase in the
GRSHDL-cholesterol (6.6% of the variance, P,10
215), of which more
than one-half can be ascribed to the number of C alleles of
rs3764261 (slope6SE: 3.36960.398 mg/dl per dose of the risk
allele, explaining 3.58% of the variance, P,10
215). Figure 2 shows
that the effects of both GRSHDL-cholesterol and rs3764261 increased
in proportion to the quantiles of the HDL distribution (P,0.0001).
Compared to their slope at the 10
th percentile, the slope at
the 90
th HDL percentile was 1.87- and 2.42-fold greater for
GRSHDL-cholesterol and rs3764261, respectively. The 95% confi-
dence interval for the standard regression slopes included only
between the 35
th and 76
th percentile of the HDL cholesterol
distribution for the GRSHDL-cholesterol (misrepresenting 58%), and
excluded those slopes above the 65
th HDL percentile for
rs3764261. The absolute differences in the slopes between the
10
th and 90
th percentiles represented 70% of the standard
regression estimate for the GRSHDL-cholesterol score, and 96% for
rs3764261. We estimate that allowing the regression slope to
increase with the percentile of the lipoprotein distribution
increased the percent of the variance explained by 7.6% for the
GRSHDL-cholesterol (from 6.61 to 7.11), and by 6.1% for rs3764261
(from 3.58% to 3.80%).
Table 1. Standard least-squares and quantile regression analyses of lipids, lipoproteins, BMI and height.
Quantile regression (slope±SE)
10
th percentile 25
th percentile 50
th percentile 75
th percentile 90
th percentile
Standard least
squares regression
LDL-cholesterol (mg/dL) vs. GRS 0.2860.10 0.6560.11 0.7760.10 0.9160.11 1.3860.20 0.8060.09
HDL-cholesterol (mg/dL) vs. GRS 0.6960.13 0.6960.10 0.7860.08 0.9860.10 1.2960.15 0.8660.07
HDL-cholesterol(mg/dL)vs.CETP(rs3764261) 2.2760.60 2.6960.43 2.9660.44 4.3860.67 5.5161.01 3.3760.40
Total cholesterol (mg/dL) vs. GRS 0.4360.10 0.5660.09 0.7060.08 1.0760.12 1.3260.18 1.0160.09
Triglycerides (mg/dL) vs. GRS 0.7460.14 0.7960.11 1.1660.13 1.5960.29 2.4660.42 1.3660.17
BMI (kg/m
2) vs. GRS 0.4460.27 0.3660.19 1.1960.26 1.5260.30 1.8860.59 0.9860.23
BMI (kg/m
2) vs. FTO (rs1558902) 0.2260.24 0.0960.19 0.6260.26 1.0760.21 1.4760.45 0.8260.20
Height (z-score) vs. GRS 1.1260.16 1.1860.13 1.1760.09 0.9860.08 0.9360.13 1.0960.08
doi:10.1371/journal.pone.0028764.t001
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Standard regression analyses showed that when adjusted for
covariates, plasma total cholesterol concentrations increased
(slope6SE) 1.01160.088 mg/dL per increase in its GRS (6.4%
of the variance, P,10
215), and plasma triglycerides increased
1.35960.167 mg/dL per increase in its GRS (3.3% of the
variance, P,10
215). Figure 3 showed that their slopes with
GRSTotal cholesterol and GRSTriglycerides increased significantly with
increasing quantiles of their distributions. Whereas total choles-
terol showed a mostly linear increase (acceleration) with increasing
quantile values, the graph for plasma triglyceride concentrations
suggested a steeper rise in its regression slopes with increasing
percentiles of the triglyceride distribution. Compared to their
slopes at the 10
th percentile, the increase in slope was 3.07-fold
larger for the 90
th percentile of the total cholesterol distribution,
and 3.34-fold larger for the 90
th percentile of plasma triglycerides.
The 95% confidence interval for the standard regression slopes
included only between the 57th and 85th percentiles of the total
cholesterol distribution (misrepresenting 71%), and between the
46th and 76th percentiles of the triglyceride distribution
(misrepresenting 69%). The absolute differences in the slopes
between the 10th and 90th percentiles exceeded the standard
regression estimate by 27% for triglycerides, and represented
about 88% of the standard regression estimate for total cholesterol.
We estimate that allowing the regression slope to increase with the
percentile of the lipoprotein distribution increased the percent of
Figure 1. Increase in LDL-cholesterol per increase in the
GRSLDL-cholesterol for selected percentiles (upper panel), and
for all percentiles as a function of the LDL-percent distribution
(lower panel). Note that the Y-axis represents LDL-cholesterol
concentrations in the upper panel, and the slopes for LDL-cholesterol
vs. GRSLDL-cholesterol in the lower panel. The correspondence between
the upper and lower panels is illustrated by the letter designation of the
corresponding slopes at the 10
th (A), 25
th (B), 50
th (C), 75
th (D), and 90
th
(E) LDL-percentile distribution. Lighter lines designate 6 one standard
error.
doi:10.1371/journal.pone.0028764.g001
Figure 2. Slopes for HDL-cholesterol versus GRSHDL-cholesterol
and the number of C alleles for rs3764261 (CEPT, Y-axis) by
percentiles of the HDL-cholesterol distribution (X-axis). Lighter
lines designate 6 one standard error.
doi:10.1371/journal.pone.0028764.g002
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to 6.40% to 6.70%) and by 27.9% for plasma triglyceride
concentrations (from 3.31% to 4.23%).
Body mass index
Standard regression analyses showed that when adjusted for
covariates, BMI increased (slope6SE) 0.98260.227 kg/m
2 per
increase in the GRSBMI (0.96% of the variance, P=1.6610
25),
almost all of which was explained by the number of T alleles for
rs1558902 in the FTO gene (slope6SE: 0.8156201 kg/m
2 per
dose of the risk allele, P=5610
25, 0.85% of the variance
explained). The proportion of the BMI variance explained was
improved by fitting separate coefficients to rs1558902 and to the
weighted combination of the 31 other SNPs (total percent of the
variance explained: 1.15%). The GRSBMI was therefore defined
by 0.807904 rs1558902+ 0.708466*the weighted combination of
the 31 other SNPs, which predicted a 1.00060.210 kg/m
2
increase per increase in the GRSBMI (P=1.8610
26).
Figure 4 displays the plot of the regression slopes for both the
GRSBMI and rs1558902 by the quantiles of the BMI distribution. For
the GRSBMI, the regression slope increased 0.0172160.0055 kg/m
2
for each 1% increment in the BMI percentile (P,0.0001). For
rs1558902, the regression slope increased 0.016560.0042 kg/m
2 for
each 1% increment in the BMI percentile (P,0.0001). The GRSBMI
had a 4.24-fold greater effect, and rs1558902 had 6.69-fold greater
effect, at the 90
th percentile than at the 10
th BMI percentile. The
figuresdisplaygenerallylinearincreasesintheslopewithinflectionsat
the extremes where the precision in estimate diminishes. The 95%
confidence interval for the standard regression slope included only
those slopes between the 29
th and the 73
rd BMI percentiles for
GRSBMI, and between the 42
rd and 75
th BMI percentiles for
rs1558902. Allowing the regression slope to increase with the
Figure 3. Slopes for plasma total cholesterol concentrations
versus GRSTotal cholesterol and plasma triglyceride concentra-
tions versus GRSTriglycerides (Y-axis) by the percentiles of the
lipid distribution (X-axis). Lighter lines designate 6 one standard
error.
doi:10.1371/journal.pone.0028764.g003
Figure 4. Slopes for BMI versus GRSBMI and rs155890 (FTO
gene, Y-axis) by the percentile of the BMI distribution (X-axis).
Lighter lines designate 6 one standard error.
doi:10.1371/journal.pone.0028764.g004
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variance explained by 24.7% for GRSBMI (from 1.15 to 1.43) and by
59.1% for rs1558902 (from 0.79 to 1.26).
Height
Standard regression analyses showed that when adjusted for
covariates, the z-score for height increased 1.08660.076 units per
increase in the GRSHeight (9.66% of the variance, P,10
215).
Figure 5 shows that the regression slope did not increase with the
percentile of the height distribution. With minor exceptions (86
th,
92
nd–94
th percentiles), the 95% confidence interval for the
standard regression slope included all slopes for height vs.
GRSHeight.
Additional analyses
The preceding analyses were redone using weights for the
individual SNPs that maximize the proportion of the variance
explained in the current sample, rather than the published effects
from meta-analyses. Using multiple regression to find the best
weights for our specific sample increased the explained variance
from 4.4% to 7.2% for LDL-cholesterol, from 6.6% to 8.8% for
HDL-cholesterol, from 6.4% to 9.5% for total cholesterol, from
3.3% to 4.4% for triglycerides, and from 1.15% to 3.09% for BMI.
Adjusting for the number of coefficients fitted had little effect on the
percent of the variance explained (i.e., adjusted R
2). On average,
each 1% increase in the quantile of the dependent variable was
associated with a 0.010660.0022 increase in the slope for LDL-
cholesterol vs. GRSLDL-cholesterol fitted (P,10
26), a 0.01026
0.0017 mg/dL increase in the slope for HDL-cholesterol vs.
GRSHDL-cholesterol fitted (P=2.4610
29), a 0.006960.0018 mg/dL
increase in the slope for total cholesterol vs. GRSTotal cholesterol fitted
(P=5610
25)a0 . 0 1 4 2 60.0027 mg/dL increase in the slope for
triglycerides vs. GRStriglycerides fitted (P=10
27), and a 0.01456
0.0032 kg/m
2 increase in the slope for BMI vs. GRSBMI fitted
(P=10
26).Compared to the 10
thquantileof the dependent variable,
the regression slope at the 90
th quantile was 2.93-fold larger for
LDL-cholesterol vs. GRSLDL-cholesterol fitted, 2.23-fold larger for
HDL-cholesterol vs. GRSHDL-cholesterol fitted, 1.78-fold larger for total
cholesterolvs. GRStotal cholesterol fitted, 3.26-foldlargerfor triglycerides
vs. GRStriglycerides fitted, and 3.73-fold larger for BMI vs.
GRSBMI fitted. We estimate that allowing the regression slopes to
increase with the percentile of the independent variable increased
the percent of the variance explained by 15.6% for LDL-cholesterol
(from 7.19 to 8.31), 12.5% for HDL-cholesterol (from 8.82 to 9.92),
6.59% for total cholesterol (from 9.48 to 10.11), 42.1% for
triglycerides (from 4.40 to 6.25), and 20.1% for BMI (from 3.09 to
3.71). Thus the increases in the regression slopes with the percentiles
of the dependent variable persisted. We also verified that the
reported findings were not artifacts of skewness or other distribu-
tional characteristics of the dependent variable. Specifically,
randomly permuting the residuals across the fitted standard
regression estimates, thereby insuring parallel increases for all
quantiles of the dependent variable, produced no significant
relationship between the regression slopes and the quantiles of the
dependent variable (analyses not displayed).
Discussion
We have shown that across a variety of traits the phenotypic
expression of genetic variation differed by the percentile of the
phenotype. We are aware of no reference to this phenomenon in
the various reviews of the analyses of SNPs. Forsooth, if the effects
of SNPs on the phenotypes as estimated by standard regression
analyses merit scientific significance, then so must their differences
across the percentile distribution of the trait, being nearly as great
or greater than the standard regression estimates themselves. The
phenomenon was demonstrated for both GRS calculated from the
published effects of allelic dose and GRS calculated from
individual effects that maximize the percent of the variance
explained for our specific dataset. These analyses do not reveal
whether these genotypes are specifically responsible for the more
extreme phenotype values, or whether the penetrance of these
genotypes was greater in subjects in the higher percentiles of the
population. Figures 1, 2, 3, 4 all show that the phenotypic variance
increases with the GRS, which would likely affect variance-
component estimates in genetic models, particularly in cases where
the significance of the effects are marginal. We believe the
phenomenon is common, and has key implications with respect to
estimating the proportion of the variance explained, the study of
gene-environment interactions, and the design of studies.
Ubiquity
Genotypic expression was shown to depend upon the percentile
of the phenotype distribution for GRSs representing the combined
effects of 31 to 52 loci. Although a few SNPs had large effects, the
majority of the GRSs represented the sum of a large number of
small to moderate size effects. Averaging over different genotype-
phenotype relationships within each GRS, some increasing, some
decreasing, and some showing no difference across the pheno-
type’s quantile distribution, might be expected to cancel each
other out, converging to the classical statistical model of the same
slope throughout the phenotype distribution, but this was not
observed. Although we lacked the statistical power to assess this
phenomenon for individual SNPs, their collective effect in the
GRS suggests that the majority of their individual effect must also
be quantile dependent. Moreover, we demonstrated that the
phenotypic expressions of the two SNPs with the strongest
association with their trait (i.e., rs3764261 vs. HDL-cholesterol,
and rs1558902 vs. BMI) increased significantly with the percentile
of the trait distribution.
Figure 5. Slopes for height versus GRSHeight (Y-axis) by the
percentile of the height distribution (X-axis). Lighter lines
designate 6 one standard error.
doi:10.1371/journal.pone.0028764.g005
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Considerable effort and expense has been spent on identifying
the associations between SNPs and traits that individually usually
explain very small portions of the phenotypic variance [1,4].
However, the combined influences of multiple SNPs into genetic
risk scores have begun to approach the contribution of other risk
factors. Standard regression analyses captured much of the
phenotypic effect associated with the genotypes examined in this
report. However, our analyses suggest that allowing the genotype’s
phenotypic expression to vary with the percentile of the trait
distribution significantly increases the proportions of phenotypic
variances explained. Allowing the rs1558902-BMI slope to
increase by 1.8127*BMIquantile-0.27054 for each percent increase
in the BMI distribution produced a larger increase in the percent
of the BMI variance explained than did the addition of all 31 other
SNPs currently associated with BMI at genome-wide statistical
significance.
Gene-environment interactions
Gene-environment interactions are surmised when the pheno-
typic expression of a genetic variant is altered by environmental
status. It has been proposed that such interaction may contribute
to the missing heritability [4]. However, if the phenotypic
expression of a genotype is quantile dependent, then an
environmental factor affecting the phenotype might increase or
diminish the expression of the genotype. This would follow from
the relationship of the genotype’s effect to the percentile of the
phenotype, rather than directly affecting the genotype’s expression
(Figure 6).
For example, the effect of rs155890 on BMI may be greater for
individuals who are more obese (Figure 4). A number of recent
articles have described a diminished effect of FTO polymorphisms
on BMI in physically active versus sedentary individuals [10–13].
The effect is universally described as a gene-environment
interaction [10–13]. However, Figure 4 suggests an alternative
explanation based on the fact that the effect of the FTO
polymorphism is diminished in lean vis-a `-vis overweight individ-
uals. Physically active individuals are leaner than sedentary
individuals because exercise causes weight loss acutely and
attenuates age-related weight gain in the long term [14,15]. Thus,
the apparent diminished effect of the FTO polymorphism with
greater physical activity may be, in part, a direct consequence of
the relationship of the genotype to quantiles of BMI as shown in
figure 4.
Figure 2 shows that the effect of rs3764261 of the CETP gene
on plasma HDL-cholesterol levels is quantile dependent. The
Etude Cas-Temoin sur 1’Infarctus du Myocarde Study reported a
strong interaction between CETP genotypes and alcohol on HDL-
cholesterol, the genotype effect purported to be absent in
teetotalers, and to increase progressively with increased alcohol
consumption [16]. Similar interactions were cited for other HDL-
related variables [16]. We hypothesize that this interaction could
be due, in part, to quantile dependence causing the effect of CETP
polymorphisms on HDL-cholesterol to be less for the lower HDL-
cholesterol levels of the teetotalers and greater for higher HDL-
cholesterol levels of heavy alcohol consumers. Similarly, reported
associations between CETP polymorphisms and the HDL-
cholesterol response to physical activity [17,18] may also reflect,
in part, quantile dependence in the relationships of CETP
polymorphisms on plasma HDL-cholesterol concentrations.
Experimental design
The best estimate of the standard regression slope is obtained by
sampling data from the two ends of the range of the independent
variable. This is part of the rationale for genetic studies that
compare the upper tail of a trait’s distribution, presumably
enriched with high-risk genotypes, with the lower tail, presumably
enriched with low-risk genotypes [7]. However, Figures 1 through
4 suggest that such comparisons may actually be between regions
of the distribution having high genetic penetrance (upper tail) and
low genetic penetrance (lower tail). The figures suggest that in
some cases, a more informative design may be to restrict sampling
to the upper population quantiles of a trait where phenotypic
differences between high- and low-risk alleles are more fully
expressed.
Quantile dependence generally as a biological
phenomenon
The effect of the percentile of the trait distribution on factors
affecting BMI and lipoprotein concentrations is not limited to their
genetic determinants. Elsewhere we have shown that the
associations of moderate-intensity physical activity (i.e., walking)
and vigorous-intensity physical activity (i.e., running) on BMI
became progressively greater with increasing percentiles of the
BMI distribution [19–22]. We have also reported that the well-
established increase in HDL-cholesterol per unit alcohol intake
was at least twice as great at the 95
th as at the 5
th quantile of the
HDL distribution [23]. There was also a significant graded
increase from the 5
th to the 95
th HDL percentile for the slopes
relating HDL to exercise [23]. Men’s HDL-cholesterol concen-
trations declined in association with fatness (BMI, waist, and chest
circumference) more sharply at the 95
th than at the 5
th percentile
of the HDL distribution [23]. BMI is a major determinant of
plasma triglyceride levels, and we have shown that compared to
the 5
th quantile of the triglyceride distribution, the rise in
triglycerides at the 95
th quantile per unit of adiposity was 14-
fold greater for BMI and 7.8-fold greater for waist circumference
in men, and 8-fold greater for BMI in women [24]. The greater
increases in triglycerides per unit of adiposity in whites than blacks,
in men than women, and in LDL-pattern B compared to pattern A
reported by others could all be explained, at least in part, to the
dependence on the triglyceride population percentiles we reported
[24].
Nonnormality and data transformations
Quantile regression is a nonparametric technique and therefore
there is no assumption of normality. Fitting the standard
regression line to all the data and then randomly permuting the
residuals among the fitted values did not produce the increases in
the regression slope with the percentiles of the phenotype
distributions, as would be expected (analyses not displayed).
However, the functions in the figures could be used to transform
the data such that the same relationship applies to all percentiles of
the phenotype. In some cases, the transformation may approxi-
mate a log transformation, suggesting multiplicative rather than
additive genetic effects.
Figure 6. Suggested interpretation of quantile-dependent
penetrance and gene-environment interaction.
doi:10.1371/journal.pone.0028764.g006
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Our analyses suggest that the most important gene-environment
interaction involves an individual’s physiological environment
within which genes are expressed. The lowest to the highest
percentiles of a physiological trait represent range of physiologic
parameters, genetic make-ups, and gene-gene interactions whose
presence may be essential for the genetic variant to be expressed.
The higher phenotypic range may represent a less regulated
physiological environment than at lower phenotypic levels and
providing more abundant substrates upon which the variant’s
expression depends. The relationships we observed for the GRSs
are unlikely due to the effects of a few SNPs, since in most cases
the effects of the individual SNPs are small. The greater genetic
influence at higher physiological values may represent the
influence of multiple loci, including enhanced synergism of gene-
gene interaction.
Materials and Methods
Human subjects
This report uses the baseline data for Caucasian participants of the
Cholesterol/Atherosclerosis Pharmacogenetics (CAP) Study and the
Pravastatin Inflammation/CRP Evaluation (PRINCE) trial [25–28].
The characteristics of the samples have been previously published
[25–27]. CAP subjects were recruited from two clinical centers:
University of California, Los Angeles, School of Medicine (Los
Angeles, CA) and San Francisco General Hospital (San Francisco,
CA) [25]. PRINCE subjects were enrolled from 1143 sites
representing 49 states and the District of Columbia, with no single
site enrolling more than 4 patients [26,27]. They were recruited on
the basis of having serum total cholesterol levels of 4.14–
10.36 mmol/L (CAP) or for having an LDL-cholesterol concentra-
tion $3.5 mmol/L or a history of myocardial infarction, stroke, or
coronary revascularization regardless of their baseline LDL-choles-
terol (PRINCE). Both studies excluded subjects for baseline use of
statins or other lipid lowering agents, pregnancy, lactation, alcohol or
drug abuse, liver disease, known statin intolerance, uncontrolled
diabetes, uncontrolled thyroid disease or abnormal thyroid function,
and likelihood for not completing the planned study based on the
judgment of their physician (PRINCE) or,90% compliance with the
study medication during a two-week run in period (CAP). The studies
differed slightly with respect to minimum age (30 and 21 years old for
CAP and PRINCE, respectively). The CAP study also excluded
persons for serum triglycerides .4.52 mmol/L or fasting glucose
.6.99 mmol/L; recent or planned change in diet or a weight change
of $4.5 kg; the use of corticosteroids, immunosuppressive drugs, or
drugs affecting the CYP3A4 system; elevated creatine phosphokinase
levels .10 times the upper limits of normal; uncontrolled
hypertriglyceridemia or blood pressure; abnormal renal function; or
recent major illness in the preceding 3 months. Additional exclusion
criteria for PRINCE were history of systemic inflammatory diseases
(rheumatoid arthritis, osteoarthritis, inflammatory bowel disease,
systemic lupus erythematous),myositis/myopathic process,or cancer;
and use of steroids or chemotherapeutic drugs within the past year or
chronic use of nonsteroidal anti-inflammatory drugs besides aspirin
(use for $2 weeks within the past year). Human use approval was
provided by the Lawrence Berkeley National Laboratory Human
Subjects Committee and all participants signed statements of
informed consent, which included permission for samples to be used
in future genomic studies.
Laboratory measurements
Plasma LDL-cholesterol concentrations in PRINCE were
measured by a Centers for Disease Control and Prevention–
standardized laboratory. For CAP, plasma total cholesterol and
triglyceride concentrations were determined by enzymatic proce-
dures on an Express 550 Plus analyzer (Ciba Corning, Oberlin,
OH) and were consistently in control as monitored by the CDC-
NHLBI standardization program. High-density lipoprotein
(HDL)-cholesterol was measured after dextran sulfate precipitation
of plasma [29], and LDL-cholesterol was calculated using the
Friedewald formula [30]. Blood specimens from each subject were
obtained after an overnight fast.
Genotyping
Genotyping was performed in two stages: 1) 304 CAP and 675
PRINCE participants were genotyped for 314,621 SNPs (Hu-
manHap300 bead chip, Illumina, San Diego, CA); and 2) 280
CAP and 652 PRINCE samples were genotyped for 620,901 SNPs
(HumanQuad610 bead chip (Illumina). Both bead chips were
designed to tag common genomic variation in Caucasians.
Additional genotypes were obtained in 292 CAP and 634
PRINCE samples that were genotyped at 12,959 sites using a
custom-made iSelect chip (N=926). These measurements were
used to infer the genotypes for approximately 2.5 million SNPs
typed in the HapMap (phase II [31]) CEU parents using the
genotype imputation software BIMBAM [32,33].
Quantile regression
Quantile regression was used to estimate the slope for the k
th
lipoprotein, BMI, or height quantile versus the GRS [34], and
bootstrap resampling to estimate their corresponding variances
and covariances [35,36]. One-thousand bootstrap samples were
drawn for their estimation. The test for whether the slopes
increased or decreased with the percentile of the dependent
variable was based on the linear contrast of the slope at the 5
th,
6
th,…, 95
th quantiles of the phenotype. All analyses were
performed using Stata (version 11, StataCorp, College Station,
TX). In the text, the terms ‘‘increase’’ and ‘‘decrease’’ are used in
the mathematical description of a function only, and do not imply
actual phenotypic changes over time.
Estimating the proportion of the variance explained
The classical regression model assumes the same regression
slope applies to all quantiles of the independent variable. This
means that when adjusting for the effect of the independent
variable, either to control for its effect in multivariate analyses or
to estimate the proportion of the variance it explains, it is
unnecessary to specify a value of the independent variable to
which the observations were adjusted. This is because the points
maintain their same relative positions when they are projected to a
common value along parallel trajectories, so all common values
yield the same results. When the regression slopes are not parallel,
the relative positions of the data points will change depending
upon the value of the independent variable to which the points are
projected. In the current analyses, the proportion of the variance
explained by the GRS was computed by projecting all observa-
tions to the mean GRS value. Specifically, for each observation
we: 1) determined the percentile rank of the lipoprotein values
within its GRS decile; 2) determined the corresponding regression
slopes; 3) determined the difference between the GRS and the
mean GRS for the entire sample; and 4) subtracted their products
from the original lipoprotein values. The regression slopes for
noninteger quantile values were found by interpolation. The
proportion of the variance explained by an individual SNP was
computed the same way, except that the observed lipoprotein
values were ranked within each genotype, and adjusted to the
mean number of doses of the risk allele.
Quantile-Specific Penetrance
PLoS ONE | www.plosone.org 7 January 2012 | Volume 7 | Issue 1 | e28764Acknowledgments
The author wishes to thank Ronald M. Krauss and his staff for providing
data from the Cholesterol Atherosclerosis Pharmacogenetics (CAP) Study
and Paul M Ridker and Daniel I. Chasman for providing data from the
Pravastatin Inflammation CRP Evaluation (PRINCE) trial.
Author Contributions
Conceived and designed the experiments: PTW. Performed the experi-
ments: PTW. Analyzed the data: PTW. Wrote the paper: PTW.
References
1. Goldstein DB (2009) Common genetic variation and human traits. N Engl J Med
360: 1696–1698.
2. Zeggini E, Ioannidis JP (2009) Meta-analysis in genome-wide association studies.
Pharmacogenomics 10: 191–201.
3. Cantor JM, Lange K, Sinsheimer JS (2010) Prioritizing GWAS Results: A review
of statistical methods and recommendations for their application. Am J Hum
Genet 86: 6–22.
4. Manolio TA, Collins FS, Cox NJ, Goldstein DB, Hindorff LA, et al. (2009)
Finding the missing heritability of complex diseases. Nature 46: 747–753.
5. Draper NR, Smith H (1998) Applied Regression Analysis John Wiley and Sons.
736 p. ISBN: 9780471170822.
6. Speliotes EK, Willer CJ, Berndt SI, Monda KL, Thorleifsson G, et al. (2010)
Association analyses of 249,796 individuals reveal 18 new loci associated with
body mass index. Nat Genet 42: 937–948.
7. Guey LT, Kravic J, Melander O, Burtt NP, Laramie JM, et al. (2011) Power in
the phenotypic extremes: a simulation study of power in discovery and
replication of rare variants. Genet Epidemiol 35: 236–246.
8. Teslovich TM, Musunuru K, Smith AV, Edmondson AC, Stylianou IM, et al.
(2010) Biological, clinical and population relevance of 95 loci for blood lipids.
Nature 466: 707–713.
9. Lango AH, Estrada K, Lettre G, Berndt SI, Weedon MN, et al. (2010)
Hundreds of variants clustered in genomic loci and biological pathways affect
human height. Nature 467: 832–838.
10. Rampersaud E, Mitchell BD, Pollin TI, Fu M, Shen H, et al. (2008) Physical
activity and the association of common FTO gene variants with body mass index
and obesity. Arch Intern Med 168: 1791–1797.
11. Andreasen CH, Stender-Petersen KL, Mogensen MS, Torekov SS, Wegner L,
et al. (2008) Low physical activity accentuates the effect of the FTO rs9939609
polymorphism on body fat accumulation. Diabetes 57: 95–101.
12. Vimaleswaran KS, Li S, Zhao JH, Luan J, Bingham SA, et al. (2009) Physical
activity attenuates the body mass index-increasing influence of genetic variation
in the FTO gene. Am J Clin Nutr 90: 425–428.
13. Scott RA, Bailey ME, Moran CN, Wilson RH, Fuku N, et al. (2010) FTO
genotype and adiposity in children: physical activity levels influence the effect of
the risk genotype in adolescent males. Eur J Hum Genet 18: 1339–1343.
14. Williams PT (2008) Asymmetric weight gain and loss from increasing and
decreasing exercise. Med Sci Sports Exerc 40: 296–302.
15. Williams PT (2007) Maintaining vigorous activity attenuates 7-yr weight gain in
8340 runners. Med Sci Sports Exerc 39: 801–809.
16. Fumeron F, Betoulle D, Luc G, Behague I, Ricard, et al. (1995) Alcohol intake
modulates the effect of a polymorphism of the cholesteryl ester transfer protein
gene on plasma high density lipoprotein and the risk of myocardial infarction.
J Clin Invest 96: 1664–1671.
17. Wilund KR, Ferrell RE, Phares DA, Goldberg AP, Hagberg JM (2002) Changes
in high-density lipoprotein-cholesterol subfractions with exercise training may be
dependent on cholesteryl ester transfer protein (CETP) genotype. Metabolism
51: 774–778.
18. Spielmann N, Leon AS, Rao DC, Rice T, Skinner JS, et al. (2007) CETP
genotypes and HDL-cholesterol phenotypes in the HERITAGE Family Study.
Physiol Genomics 31: 25–31.
19. Williams PT (2008) Association between walking distance and percentiles of
body mass index in older and younger men. Br J Sports Med 42: 352–356.
20. Williams PT (2004) Exercise and the population distribution of body weight.
Int J Obes 28: 120–128.
21. Williams PT (2005) Nonlinear relationships between weekly walking distance
and adiposity in 27,596 women. Med Sci Sports Exerc 37: 1893–1901.
22. Williams PT, Satariano WA (2005) Relationships of age and weekly running
distance to BMI and circumferences in 41,582 physically active women. Obes
Res 13: 1370–1380.
23. Williams PT (2004) The relationships of vigorous exercise, alcohol, and adiposity
to low and high high-density lipoprotein-cholesterol levels. Metabolism 53:
700–709.
24. Williams PT (2004) Relationship of adiposity to the population distribution of
plasma triglyceride concentrations in vigorously active men and women.
Atherosclerosis 174: 363–371.
25. Barber MJ, Mangravite LM, Hyde CL, Chasman DI, Smith JD, et al. (2010)
Genome-wide association of lipid-lowering response to statins in combined study
populations. PLoS One 5: e9763.
26. Simon JA, Lin F, Hulley SB, Blanche PJ, Waters D, et al. (2006) Phenotypic
predictors of response to simvastatin therapy among African-Americans and
Caucasians: the Cholesterol and Pharmacogenetics (CAP) Study. Am J Cardiol
97: 843–850.
27. Albert MA, Danielson E, Rifai N, Ridker PM (2001) Effect of statin therapy on
C-reactive protein levels: the pravastatin inflammation/CRP evaluation
(PRINCE): a randomized trial and cohort study. JAMA 286: 64–70.
28. Chasman DI, Posada D, Subrahmanyan L, Cook NR, Stanton Jr. VP,
Ridker PM (2004) Pharmacogenetic study of statin therapy and cholesterol
reduction. JAMA 291: 2821–2827.
29. Warnick GR, Nguyen T, Albers AA (1985) Comparison of improved
precipitation methods for quantification of high-density lipoprotein cholesterol.
Clin Chem 31: 217–222.
30. Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the
concentration of low-density lipoprotein cholesterol in plasma, without use of
the preparative ultracentrifuge. Clin Chem 18: 499–502.
31. International HapMap Consortium, Frazer KA, Ballinger DG, Cox DR,
Hinds DA, et al. (2007) A second generation human haplotype map of over 3.1
million SNPs. Nature 449: 851–861.
32. Servin B, Stephens M (2007) Imputation-based analysis of association studies:
candidate regions and quantitative traits. PLoS Genet 3: e114.
33. Guan Y, Stephens M (2008) Practical issues in imputation-based association
mapping. PLoS Genet 2008;4: e1000279.
34. Koenker R, Hallock KF (2001) Quantile regression. J Economic Perspectives 15:
143–56.
35. Efron B (1982) The jackknife, the bootstrap and other resampling plans.
Philadelphia: Society for Industrial and Applied Mathematics. 92 p.
36. Gould WW (1992) Quantile regression with bootstrapped standard errors. Stata
Technical Bulletin 9: 19–21.
Quantile-Specific Penetrance
PLoS ONE | www.plosone.org 8 January 2012 | Volume 7 | Issue 1 | e28764